HUP0600237A2 - Pharmaceutical tablet comprising paroxetine mesylate - Google Patents

Pharmaceutical tablet comprising paroxetine mesylate

Info

Publication number
HUP0600237A2
HUP0600237A2 HU0600237A HUP0600237A HUP0600237A2 HU P0600237 A2 HUP0600237 A2 HU P0600237A2 HU 0600237 A HU0600237 A HU 0600237A HU P0600237 A HUP0600237 A HU P0600237A HU P0600237 A2 HUP0600237 A2 HU P0600237A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical tablet
paroxetine mesylate
paroxetine
mesylate
tablet
Prior art date
Application number
HU0600237A
Other languages
English (en)
Inventor
Theodorus Hendricus Ant Peters
Dalen Frans Van
Jacobus Maria Lemmens
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of HUP0600237A2 publication Critical patent/HUP0600237A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0600237A 2001-01-11 2001-12-20 Pharmaceutical tablet comprising paroxetine mesylate HUP0600237A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE20100529U DE20100529U1 (de) 2001-01-11 2001-01-11 Pharmazeutische Tablette umfassend Paroxetinmesylat
PCT/EP2001/015115 WO2002055062A2 (en) 2001-01-11 2001-12-20 Pharmaceutical tablet comprising paroxetine mesylate

Publications (1)

Publication Number Publication Date
HUP0600237A2 true HUP0600237A2 (en) 2006-11-28

Family

ID=7951516

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0600237A HUP0600237A2 (en) 2001-01-11 2001-12-20 Pharmaceutical tablet comprising paroxetine mesylate

Country Status (9)

Country Link
US (1) US20040086559A1 (hu)
EP (1) EP1353652A2 (hu)
CZ (1) CZ20031899A3 (hu)
DE (1) DE20100529U1 (hu)
HU (1) HUP0600237A2 (hu)
NO (1) NO20033162D0 (hu)
PL (1) PL362701A1 (hu)
WO (1) WO2002055062A2 (hu)
ZA (1) ZA200305157B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
WO2005034954A2 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN102525966B (zh) * 2010-12-13 2016-06-29 江苏万全特创医药生物技术有限公司 一种含有帕罗西汀的片剂及其制备方法
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
GB201500512D0 (en) 2015-01-13 2015-02-25 Soe Health Ltd Therapeutic treatment methods, and apparatus for use therein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
CA2293247C (en) * 1997-06-10 2005-04-12 Synthon B.V. 4-phenylpiperidine compounds
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
NO20033162L (no) 2003-07-10
WO2002055062A2 (en) 2002-07-18
WO2002055062A3 (en) 2003-03-13
PL362701A1 (en) 2004-11-02
CZ20031899A3 (en) 2004-03-17
US20040086559A1 (en) 2004-05-06
ZA200305157B (en) 2004-08-17
DE20100529U1 (de) 2001-05-10
NO20033162D0 (no) 2003-07-10
EP1353652A2 (en) 2003-10-22

Similar Documents

Publication Publication Date Title
GB0117618D0 (en) Pharmaceutical dosage form
MXPA03009971A (es) FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO.
GB0102342D0 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
GB0104534D0 (en) Pharmaceutical combination
GB0117619D0 (en) Pharmaceutical dosage form
PL366510A1 (en) Pharmaceutical combinations
PL366432A1 (en) Pharmaceutical formulation
HK1062896A1 (en) Swallow tablet comprising paracetemol
GB0124523D0 (en) Pharmaceutical combination
HUP0600237A2 (en) Pharmaceutical tablet comprising paroxetine mesylate
GB0129270D0 (en) Pharmaceutical combination
GB0129397D0 (en) Pharmaceutical combination
GB0129872D0 (en) Novel pharmaceutical
GB0129395D0 (en) Pharmaceutical combination
AU2002235803A1 (en) Pharmaceutical tablet comprising paroxetine mesylate
PL355453A1 (en) Pharmaceutical agent
GB0128138D0 (en) Pharmaceutical use
GB0129876D0 (en) Novel pharmaceutical
GB0130509D0 (en) Novel pharmaceutical
GB0130510D0 (en) Novel pharmaceutical
GB0130511D0 (en) Novel pharmaceutical
GB0104749D0 (en) Pharmaceutical formulation
GB0129871D0 (en) Novel pharmaceutical
UA5530S (uk) Таблетка фармацевтична

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees